bicalutamide has been researched along with panobinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, AC; Gomez-Pinillos, A; Johnson, EM; Liu, X | 1 |
| Alumkal, JJ; Babb, J; Barnett, ES; Beer, TM; DiPaola, R; Ferrari, AC; Gomez-Pinillos, A; Liu, X; Moore, D; Stein, MN; Taplin, ME | 1 |
1 trial(s) available for bicalutamide and panobinostat
| Article | Year |
|---|---|
Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer.
Topics: Aged; Androgen Antagonists; Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Male; Mice; Middle Aged; Nitriles; Panobinostat; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Tosyl Compounds; Xenograft Model Antitumor Assays | 2019 |
1 other study(ies) available for bicalutamide and panobinostat
| Article | Year |
|---|---|
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels.
Topics: 5' Untranslated Regions; Androgen Antagonists; Anilides; Apoptosis; Cell Cycle; Cell Line, Tumor; DNA-Binding Proteins; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Male; Nitriles; Orchiectomy; Panobinostat; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Transcription Factors | 2010 |